ALPS Alps Group Inc
Healthcare$0.71+0.00%OpenMarket Cap: $118.4M
As of 2026-05-26
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
-0.21
P/S
33.24
EV/EBITDA
-1.76
DCF Value
$-0.02
FCF Yield
-0.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
38.6%
Operating Margin
-1983.1%
Net Margin
-2004.5%
ROE
922.4%
ROA
-3884.2%
ROIC
5301.1%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 null | $0.00 | $-828.4K | $— |
| Q2 null | $0.00 | $-893.9K | $— |
| Q4 null | $3.4M | $-65.1M | $— |
| Q1 null | $0.00 | $-738.6K | $— |
Trading Activity
Insider Trades
View AllLee Hee Hangdirector
SellMon Apr 20
Poh Chit Laaofficer: See Remarks
SellTue Mar 24
Chua Boon Pingdirector
SellTue Mar 24
Chew Yoke Lingdirector
SellTue Mar 24
Cheing Lye-Pingofficer
SellTue Mar 24
Company Info
Sector
Healthcare
Industry
Biotechnology
Country
MY
Exchange
—
Beta
-0.08
Alps Group Inc is an integrated biotechnology platform providing research and development, medical services, and wellness solutions focused on advanced therapies. The company aims to create a fair healthcare ecosystem with accessible predictive, preventive, and precision medicine.